14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CRNT vs SENS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CRNT Overall Winner
6-Pillar Tally: CRNT 4 – 2 SENS
Matrix Metrics: CRNT 6 – 4 SENS
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Senseonics Holdings, Inc. (SENS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin), whereas SENS carries 38.8/100 (SELL) at $11.03 (21.0x Forward P/E, -201.0% operating margin).
Composite vs. Pillar Nuance: While SENS currently prints a higher short-term Unified Composite Score (38.8/100 SELL vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -201.0% operating margin) and revenue trajectory (+11.7% vs. +141.6% YoY).
Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CRNT (26.6/100 SELL) and SENS (38.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 66.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Communication Equipment value chain with $217.2M market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment30.6% of Rev ($109M)
90D Engineering Disclosures0 Published
SENS Moat ProfileCyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $569.4M market capitalization and -201.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CRNT vs SENS Key Questions & Quantitative Answers
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Senseonics Holdings, Inc. (SENS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin), whereas SENS carries 38.8/100 (SELL) at $11.03 (21.0x Forward P/E, -201.0% operating margin). Composite vs. Pillar Nuance: While SENS currently prints a higher short-term Unified Composite Score (38.8/100 SELL vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -201.0% operating margin) and revenue trajectory (+11.7% vs. +141.6% YoY). Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CRNT (26.6/100 SELL) and SENS (38.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 66.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SENS leads the Growth & Scale pillar: CRNT posts +11.7% YoY revenue growth and N/A YoY earnings growth on $357M TTM revenue (34.1% gross margin, 3.5% operating margin), compared with SENS at +141.6% YoY revenue growth and +0.0% YoY earnings growth on $60M TTM revenue (58.7% gross margin, -201.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CRNT cumulative revenue shifted +0.0% while SENS shifted +100.0%. In operating R&D and SG&A reinvestment, CRNT deploys 30.6% of Rev ($109M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SENS.
CRNT screens cheaper on headline valuation multiples. CRNT trades at 13.7x Forward P/E, 15.7x Trailing P/E, 8.80x PEG, and 0.6x EV/Revenue (3.6% FCF margin), whereas SENS trades at 21.0x Forward P/E, 21.0x Trailing P/E, N/M PEG, and 9.7x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRNT (-0.5% ROE) versus SENS (-157.3% ROE) capital efficiency.
In options market volatility and institutional positioning, CRNT carries 43.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.84β · 77% Vol realized risk). By comparison, SENS carries 68.8% implied volatility (35th %ile, Balanced (25th–60th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.96β · 102% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.